Menu

Website Search

Cyramzahcp.com

cyramzahcp.com
Visit cyramzahcp.com

  • 6 months ago

    Last scanned

  • 10 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

CYRAMZA® (ramucirumab) | VEGFR2 Inhibitor

CYRAMZA® is approved for the treatment of patients with advanced or metastatic stomach or gastroesophageal (GE) junction cancer, metastatic NSCLC, metastatic CRC, and AFP-High liver cancer (HCC).

Cyramzahcp.com thumbnail
Cyramzahcp.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Amazon Technologies Inc., which reserves the following IP addresses for cyramzahcp.com: 18.205.36.100, 52.204.242.176, 54.157.58.70, 54.162.128.250. Moreover, DNS used with this website include pdns108.ultradns.biz, pdns108.ultradns.com, pdns108.ultradns.net, pdns108.ultradns.org. Subnet identifier ranges from 18.32.0.0 to 18.255.255.255. Classless Inter-Domain Routing (CIDR) is 18.64.0.0/10, 18.32.0.0/11, 18.128.0.0/9. ARIN net type is Direct Allocation.

  • 6 months ago

    Last scanned

  • 10 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of cyramzahcp.com is GoDaddy Corporate Domains, LLC and the name expires on 2024-08-27. According to open source data, you can reach the owner at admin_global_domain@lilly.com but please make sure you have a good reason for unsolicited messages. Their country of residence is United States of America.

  • lung cancer
  • gej
  • progressed
  • nccn guidelines
  • Gastric Cancer
  • metastatic colorectal cancer
  • gastroesophageal junction cancer
  • CYRAMZA
  • cyramza package insert
  • second-line

Websites similar to cyramzahcp.com